Sigurdsson H - Search Results

1

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Among authors: sigurdsson h. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

2

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.

Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D. Baldetorp B, et al. Among authors: sigurdsson h. Cytometry. 1992;13(6):577-85. doi: 10.1002/cyto.990130605. Cytometry. 1992. PMID: 1451590 Free article.

3

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

Fernö M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: sigurdsson h. Cytometry. 1992;13(3):241-9. doi: 10.1002/cyto.990130305. Cytometry. 1992. PMID: 1576890 Free article.

4

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Among authors: sigurdsson h. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

5

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: sigurdsson h. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

6

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

Olsson H, Borg A, Fernö M, Ranstam J, Sigurdsson H. Olsson H, et al. Among authors: sigurdsson h. J Natl Cancer Inst. 1991 Oct 16;83(20):1483-7. doi: 10.1093/jnci/83.20.1483. J Natl Cancer Inst. 1991. PMID: 1920494

7

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. Borg A, et al. Among authors: sigurdsson h. Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070

8

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Among authors: sigurdsson h. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

9

Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.

Olsson H, Ranstam J, Baldetorp B, Ewers SB, Fernö M, Killander D, Sigurdsson H. Olsson H, et al. Among authors: sigurdsson h. Cancer. 1991 Mar 1;67(5):1285-90. doi: 10.1002/1097-0142(19910301)67:5<1285::aid-cncr2820670502>3.0.co;2-q. Cancer. 1991. PMID: 1991290

10

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters